Background: There is limited literature documenting hemichorea-hemiballism (HCHB) resulting from co-infection of toxoplasmosis and tuberculosis (TB) in acquired immunodeficiency syndrome (AIDS). Toxoplasmic abscess is the most common cause while TB is a rare etiology.
Case Description: We describe a 24-year-old male with AIDS-related HCHB as the presentation of cerebritis on the right subthalamic nucleus and cerebral peduncle from intracranial toxoplasma and TB co-infection. Antimicrobials and symptomatic therapy were given. Marked improvement was seen on follow-up.
Discussion: HCHB may be the initial presentation of intracranial involvement of this coinfection in the setting of AIDS and is potentially reversible with timely management.
The prevalence of movement disorders among human immunodeficiency virus (HIV)-infected adult population ranges from 2% to as high as 44%, with hemichorea-hemiballism (HCHB) being one of the most common presentations . HCHB is a hyperkinetic movement disorder characterized by involuntary, irregular movements of variable amplitude affecting one side of the body . Although the two phenomenologies share a similar pathophysiology, proximally predominant, high-amplitude movements are ascribed to ballism, while more distal, lower amplitude movements are often termed chorea [2, 3]. HCHB in this population is almost invariably caused by a mature toxoplasmic abscess in the subthalamic nucleus (STN) [1, 4] in a Toxoplasma-seropositive patient and often in the setting of established acquired immunodeficiency syndrome (AIDS) [1, 4] as summarized in Table 1. However, because the diagnosis of toxoplasmosis is often presumptive  and the imaging findings are non-specific [32, 33, 34], other common opportunistic infections that may cause the movement disorder must also be considered . HIV-infected adults are 21–37 times more likely to acquire tuberculosis in particular , and those with systemic TB are five times more predisposed to have central nervous system involvement . Although rare, HCHB may be secondary to intracranial TB complicated by infarctions, TB abscess or tuberculomas as seen in Table 1 [25, 28]. There is limited literature documenting HCHB as a result of opportunistic co-infections of toxoplasmosis and TB in HIV/AIDS patients. Here, we present the atypical case of an adult male with AIDS-related HCHB as the initial presentation of intracranial involvement from these infections.
|AUTHOR & YEAR||NO. OF CASES||AGE IN YEARS/SEX||HIV STATUS (CD4 COUNT)†||MODE OF ONSET AND SITE||INVESTIGATIONS||TREATMENT||CLINICAL OUTCOME||RADIOLOGIC RESPONSE|
|Cerebral toxoplasmosis (Total number of cases = 29)|
|Navia  1986||2||Pt 1: NR/M||+||Chronic, chorea of four limbs||CT: bilateral BG hypodense lesions, positive T. gondii serology, autopsy revealed T. gondii tachyzoites on multiple brain lesions||Pyr, sulfadiazine||Death||NR|
|Pt 2: NR/M||+||Chronic, left choreoathetosis||CT: left internal capsule and right occipital abscess, positive T. gondii serology, autopsy revealed T. gondii tachyzoites on multiple brain lesions including BG and thalamus||Pyr, sulfadiazine||Death||NR|
|Nath  1987||3||Pt 1: 26/F||+||NR, right HCHB||CT: left BG and frontal abscess, positive T. gondii titers in CSF, positive CSF cryptococcal antigen||NR||Improved||Improved|
|Pt 2: 56/M||+||NR, right HB||CT: normal, positive T. gondii titers in CSF, autopsy showed toxoplasmosis abscess on left STN||NR||Death||NR|
|Pt 3: 47/M||+||NR, right HCHB||CT: left BG and cerebral hemisphere abscess, positive T. gondii serology||NR||NR||NR|
|Dewey  1989||2||Pt 1: 26/F||+||Acute, right HCHB, right face||CT or MRI: left BG or frontal lobe Toxoplasma abscess||Haloperidol||Partial recovery||NR|
|Pt 2: 47/M||+||Acute, right HCHB||CT or MRI: left BG or cerebral hemisphere Toxoplasma abscess||Pyr sulfate||Partial recovery||NR|
|Sanchez-Ramos  1989||1||33/F||+||Subacute, left HCHB||CT: right STN, thalamus, cerebellum and left caudate abscess, positive T. gondii serology||Pyr, sulfadiazine||Complete recovery at 2 mo§||Marked resolution at 20 d|
|Awada  1993||1||33/F||+||Subacute, right HB||CT: left thalamus and STN lesion, negative T. gondii serology||Pyr, sulfadiazine||Complete recovery at 6 w||Complete resolution at 6 w|
|Nath  1993||1||32/M||+||Chronic, left HCHB, left face||CT: right globus pallidus, bilateral cerebral hemisphere abscess, positive T. gondii serology||Pyr, sulfadiazine, haloperidol||Partial recovery at 10 d§||Partial resolution at 10 d|
|Garretto  1995||1||26/M||+ (218)||Subacute, left HCHB||MRI: right cerebral peduncle, frontal and left temporo-occipital abscess, positive T. gondii serology||Pyr, sulfadiazine, haloperidol||Minimal recovery||Partial resolution after 6 w|
|Manji  1995||1||28/F||+||Subacute, right choreoathetosis||CT: bilateral lentiform nuclei, thalami, cerebral hemisphere lesions, positive T. gondii serology||Pyr, sulfadiazine||Partial recovery at 5 w||Complete resolution at 5 mo|
|Krauss  1996||1||32/M||+||Subacute, right HB||CT or MRI: abscess in left STN from toxoplasmosis||Antitoxoplasmosis; underwent cervical ventrolateral chordotomy||No recovery with medication; complete recovery after surgery at 6 mo||Complete resolution|
|Maggi  1996||3||Pt 1: 27/M||+ (50)||NR, left arm choreoathetosis||MRI: right thalamic, bilateral hemisphere abscess from toxoplasmosis||Pyr, sulfadiazine||Complete recovery at 1 mo||NR|
|Pt 2: 31/M||+ (30)||NR, left HCHB||MRI: right caudate, STN abscess from toxoplasmosis||Pyr, sulfadiazine||Complete recovery at 1 mo||Complete resolution at 4 mo|
|Pt 3: 32/M||+ (30)||NR, left choreoathetosis||MRI: right STN, midbrain and bilateral hemisphere abscess from toxoplasmosis||Pyr, sulfadiazine||Complete recovery at 10 d||Complete resolution at 3 mo|
|Piccolo  1999||2||Pt 1: 27/M||+||Acute, right HC||CT and MRI: abscess in left STN, positive T. gondii serology||Pyr and sulfamethopyrazine||Complete recovery at 2 mo||Complete resolution at 1 mo|
|Pt 2: 35/M||+ (10)||Acute, chorea of four limbs, face and mouth||MRI: abscess in right cerebral peduncle and BG, left occipital, temporal thalamocapsular and frontal operculum, autopsy revealed T. gondii tachyzoites on circular brain lesions||NR||Death||NR|
|De Mattos  2002||6||Mean age 32.5 (Range: 27 to 40)/all male||+||Acute, left HCHB in 5 cases, right HCHB in 1 case||Ring enhancing lesions in striatum or in the frontal lobe suggestive of toxoplasmosis||NR||NR||NR|
|Piccolo  2003||2||Pt 1: 27/NR||+||NR, hemichorea||Toxoplasma abscess in contralateral STN||NR||Complete recovery at 6 mo||NR|
|Pt 2: 35/NR||+||NR, generalized chorea||Pathologically confirmed toxoplasmosis in BG||NR||Death||NR|
|Rabhi  2011||1||59/F||+ (91)||Chronic, left HCHB||MRI: right capsulothalamic abscess, positive T. gondii serology||TMP/SMX||Complete recovery at 2 w||Marked resolution|
|Sta. Maria  2012||1||30/M||+||Acute, left HC||MRI: Abscess in cerebral peduncle and frontal lobe, positive T. gondii serology||TMP/SMX||NR||NR|
|Moccia  2013||1||32/F||+ (250)||Subacute, right HCHB||MRI: ring enhancing lesion in left caudate to midbrain, T. gondii IgG positive 25 UI/mL||Pyr, sulfadiazine, haloperidol, ART||Complete recovery at 3 mo||Small residual lesion in the midbrain at 3 mo|
|Intracranial tuberculosis (Total number of cases = 23)|
|Bedwell  1960||1||39/M||NR||Subacute, left HC||Autopsy revealed tuberculoma in the right STN||Anti-TB||Death||NR|
|Riela  1982||1||11 mo/M||NR||Subacute, left choreoathetosis||CT: hypodensity in right BG, positive M. tuberculosis CSF culture, positive PPD||HR||Complete recovery||NR|
|Delaporte  1983||1||33/NR||NR||NR, left HB||CT: tuberculoma in right STN||Anti-TB||Complete recovery at 1 y||Marked resolution at 1 y|
|Babikian  1985||1||2.5/M||NR||Acute, right HCHB||CT: bilateral BG infarct, hydrocephalus, positive M. tuberculosis CSF culture||HR, streptomycin, diphenhydramine||Partial recovery at 1 y||NR|
|Alarcón  2000||7**||Range: 0.5 to 27/4 male, 3 female||NR||Acute to subacute, 3 HC, 4 generalized chorea||5 cases of definite TB meningitis, 2 probable TB meningitis, HC cases had infarcts in contralateral thalamus, caudate or internal capsule; generalized chorea cases had cortico-subcortical atrophy, hydrocephalus or bilateral caudo-capsular infarct||Anti-TB||2 with complete recovery, 3 with partial recovery, 2 died at 2 y||NR|
|Kalita  2003||1||16/F||– (191)||Subacute, left HC, left face||CT: tuberculoma in right caudate and putamen, hydrocephalus and meningeal enhancement, positive CSF acid-fast bacillus smear, right upper fibrocavitary lesion on CXR||HRZE||Marked improvement at 1 w, complete recovery at 3 mo||NR|
|Ozer  2006||1||78/M||–||Chronic, right HCHB||MRI: tuberculoma in the left thalamus, STN and midbrain, positive PPD||HRZE||Partial recovery at 6 mo, complete recovery at 2 y||Partial resolution at 6 mo|
|Alarcón  2011||8††||Pt 1: 9/F||NR||Subacute, left HC||CT or MRI: tuberculoma in frontal region and right thalamus, hydrocephalus||Anti-TB||Complete recovery at 1 y||NR|
|Pt 2: 16/F||NR||Subacute, generalized chorea||CT or MRI: tuberculoma in left thalamus, hydrocephalus||Anti-TB||Complete recovery at 1 y||NR|
|Pt 3: 28/F||NR||Subacute, right HC||CT or MRI: tuberculoma in left thalamus and frontoparietal region, hydrocephalus||Anti-TB||Complete recovery at 1 y||NR|
|Pt 4: 22/M||NR||Subacute, right HC||CT or MRI: tuberculoma in left caudate and thalamus, hydrocephalus||Anti-TB||Partial recovery at 1 y||NR|
|Pt 5: 8/F||NR||Subacute, right HC||CT or MRI: tuberculoma in left thalamus and parietal region, right cerebellum||Anti-TB||Complete recovery at 1 y||NR|
|Pt 6: 17/F||NR||Subacute, right arm chorea||CT or MRI: left frontotemporal tuberculoma||Anti-TB||Partial recovery at 1 y||NR|
|Pt 7: 42/F||NR||Subacute, right arm chorea||CT or MRI: right cerebellar tuberculoma||Anti-TB||Death||NR|
|Pt 8: 27/F||NR||Subacute, right HC||CT or MRI: tuberculoma in left frontotemporal region and thalamus||Anti-TB||Partial recovery at 1 y||NR|
|Pinto  2013||1||14/F||–||Acute, right HC||MRI: left caudate and lenticulo-capsular infarct, diagnosed miliary TB (meningitis and pulmonary disease)||HRZE||NR||NR|
|Rubio-Hernandez  2020||1||33/F||–||Subacute, left HCHB||MRI: multiple tuberculomas in right thalamus, STN, cerebral peduncle, cerebellum and subcortical white matter, positive CSF M. tuberculosis PCR, CXR showed miliary pattern and left nodular lesion||HRZE, olanzapine||Complete resolution at 6 mo||Partial resolution at 1 mo|
A 24-year-old man presented in our emergency department with a three-day history of involuntary movements of the left extremities. These were described as non-suppressible, mildly disabling, relieved by sleep, and rapidly progressing in frequency and amplitude. Few hours prior to admission, the movements became more violent and involved his left lower limb making ambulation difficult. There were no changes in sensorium nor other focal symptoms. He was diagnosed two months earlier with HIV infection after presenting with weight loss, fever and draining cervical lymph nodes. Lymph node biopsy revealed positive acid-fast bacillus (AFB) smear while his chest radiograph was consistent with pulmonary TB, for which he was started on isoniazid, rifampicin, pyrazinamide and ethambutol (HRZE). His family, medication and toxicologic history were unremarkable. On examination, he was cachectic, tachycardic, normotensive and afebrile. He had multiple, non-tender right cervical lymph nodes with scanty serosanguinous discharge. He was awake and conversant, but had subtle difficulty following complex commands. Funduscopic examination was normal with no evidence of Kayser-Fleischer rings. Cranial nerve examination did not show any abnormalities nor facial involuntary movements. He had random, purposeless, dance-like, intermittently flinging movements of the left extremities that resulted in shrugging and internal rotation of the shoulder, as well as random flexion-extension and pronation-supination of the distal upper limb. His gait was interrupted by sudden, irregular internal rotation of the hip, flexion-extension of the knee, and inversion-eversion of the foot (Video, Segment 1). These movements were consistent with left HCHB. His limbs were normotonic with 4/5 motor strength on the left extremities. The rest of the examination was normal.
On laboratory testing, he had leukopenia with a peripheral white blood cell count of 4.2 × 109/L and a peripheral blood smear showing slight poikilocytosis with no acanthocytes. He had elevated erythrocyte sedimentation rate at 121 mm/hour (normal values [NV]: 0–15) and C-reactive protein at >12 mg/L (NV: <6). He had mild hyponatremia with a sodium of 133 mmol/L (NV: 137–145 mmol/L), while his random blood sugar, liver, kidney and thyroid function tests were normal. His chest radiograph revealed bilateral apical nodular infiltrates, while abdominal imaging was unremarkable. Given the aforementioned past history, we investigated for possible infectious etiologies of the patient’s HCHB. He had a positive HIV Western blot test assay and a CD4 count of 92/mL on admission. His serum toxoplasma IgG was markedly elevated at >300 IU/mL (NV: <8) while syphilis and anti-streptolysin O (ASO) titers were negative. Cranial magnetic resonance imaging (MRI) revealed a focal cerebritis in the right STN and right cerebral peduncle (Figure 1, A–D) as well as a left frontal abscess formation (Figure 1, E–H). A lumbar puncture was performed with an opening pressure of 20 cmH20 (NV: 8–18 cmH20). His cerebrospinal fluid (CSF) was acellular with protein at 89 mg/dL (NV: 12–60) and glucose at 45.45 mg/dL (NV: 40–70), the latter being 29% of the serum level. CSF TB polymerase chain reaction (PCR) was positive while CSF culture for M. tuberculosis had no growth. CSF AFB smear, cryptococcal antigen, bacterial and fungal cultures were all negative.
With these clinicoradiologic findings, we managed him as a case of acute left HCHB secondary to a right focal cerebritis from concurrent presumptive cerebral toxoplasmosis and definite intracranial tuberculosis. He was immediately started on oral trimethoprim/sulfamethoxazole (TMP/SMX) for the toxoplasmosis. His anti-TB regimen consisted of HRZE for two months and isoniazid/rifampicin for 10 months. To address his ballistic movements, he was given risperidone which was titrated up to 2 mg/day. His HCHB were most evident during his waking hours and remained of moderate severity, necessitating measures to avoid limb injury. He was discharged after three weeks on the previously described treatment regimen, with minimal change in his HCHB. At one-month follow-up, we noted significant reduction in his HCHB. Due to the evident clinical improvement, TMP/SMX dose was reduced at two months after discharge. Antiretroviral therapy was started during this time, while his anti-TB medications were continued. A surveillance cranial contrast-enhanced computed tomography (CT) was done after four months of treatment demonstrating complete resolution of his cerebral lesions. At ninth-month follow-up, there were only occasional mild, non-disabling choreoathetoid movements of the left arm (Video, Segment 2), allowing discontinuation of risperidone. Figure 2 summarizes the timeline of events and the management done.
Our case affirms the characteristics of HCHB among reported cases of chorea-ballism in HIV-infected adults [1, 4] namely, the (1) presence of an identified structural pathology in the contralateral STN and midbrain believed to cause the chorea, (2) the hemidistribution, (3) multiplicity of the lesions, (4) acute onset , (5) lack of facial involvement which has only been seldom reported [7, 10, 15] and finally, (6) the eventual clinical and radiologic improvement seen [1, 4].
To our knowledge, our case is the first to document HCHB associated with cerebral toxoplasmosis that is in conjunction with intracranial TB infection occurring in the setting of HIV infection [1, 10]. The HCHB in this case heralded the presence of AIDS-defining opportunistic infections, which is a distinct stage of HIV disease  complicated by neurological abnormalities in as high as 60% of patients [4, 37]. In patients with movement disorders associated with AIDS, identifying the opportunistic infection is the initial goal of management . When HCHB occurs in this setting, a singular infectious etiology, primarily toxoplasmosis, is more commonly pursued which if negative, prompts consideration of alternative causes [1, 4]. However, our case illustrates that in the appropriate clinical context, more than one intracranial infection is possible and should be sought. In contrast to published literature [1, 4], HCHB in our case was from a cerebritis that may represent a beginning tuberculoma or a toxoplasmic abscess. Cerebritis is a nondescript area of parenchymal inflammation due to altered vascular permeability that heralds the development of an abscess and is seen on MRI as an area of hyperintensity on T2 weighted imaging, often with patchy contrast enhancement [38, 39]. This is already a known early stage of toxoplasmic encephalitis  although other factors in our case led to the presumptive diagnosis of cerebral toxoplasmosis, namely, the presence of HCHB, multifocality of the brain lesions, T. gondii seropositivity and low CD4 count . On the other hand, although TB cerebritis is very rare , the positive CSF TB PCR  and the MRI characteristics of the left frontal lobe lesion corroborated its tuberculous nature [40, 41]. The rarity of TB cerebritis may be attributed to its delayed clinical presentation, which typically only manifests when mass effect ensues . This case also demonstrates that a deep location as well as the presence of multiple focal tuberculous lesions may influence the appearance of movement disorders as suggested in Alarcón’s cohort of 49 patients with tuberculoma . Although we believe that both infections were contributory to the HCHB at the time of presentation, one limitation encountered was the lack of baseline neuroimaging, CD4 count and HIV viral load at the time of initial HIV and TB diagnosis, which could have helped elucidate the temporality of these infections in relation to HCHB.
Literature on concomitant intracranial co-infections in AIDS patients is limited, with a frequency of coexistent neurological diseases in this population ranging from 9% to 24% . Currently, there are no studies describing their interplay as an underlying mechanism for HCHB, whether in the presence or absence of HIV infection. Acute disruption and altered firing rate of the STN and its efferent pathways due to a destructive focus, in addition to the direct effects of HIV on the basal ganglia circuitry, possibly contribute to the pathogenesis of chorea-ballism in this population [2, 20, 27, 28, 37, 43]. As is usually the case among AIDS patients, multiple conditions may affect a portion of the nervous system simultaneously  and it is imperative to address these with adequate antimicrobial therapy.
The most effective treatment  in this case of co-infection remains to be trimethoprim/sulfamethoxazole , which is locally available, as well as HRZE . The subsequent treatment response obviated the need for biopsy [31, 44]. While we could not entirely discount its benefit in the acute phase, long-term symptomatic therapy with risperidone was no longer necessary in our case as this is commonly reserved for those with persistent or disabling symptoms [4, 37]. Although response of chorea-ballism to antitoxoplasmosis and anti-TB therapy is variable [1, 4, 20], the marked improvement seen in our patient may attest to the reversible nature of AIDS-related HCHB, as is often seen after treatment . Other factors that may affect overall prognosis of intracranial toxoplasmosis and TB include timing of diagnosis and therapy, clinical stage of the disease, and progression of neurological involvement [20, 31, 35].
In conclusion, this case demonstrates that HCHB may be the initial presentation of intracranial involvement of concomitant toxoplasmosis and TB in the setting of HIV infection. AIDS-related HCHB is potentially reversible with timely diagnosis and treatment.
Consent was obtained from the patient in writing this report. All patients who appeared on video have provided written informed consent; authorization for the video recording and for publication of the video was provided.
The authors would like to thank the patient for his participation and collaboration.
The authors have no competing interests to declare.
Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W. Movement disorders and AIDS: A review. Park Relat Disord. 2004; 10(6): 323–34. DOI: https://doi.org/10.1016/j.parkreldis.2004.03.001
Postuma RB, Lang AE. Hemiballism: Revisiting a classic disorder. Lancet Neurol. 2003; 2(11): 661–8. DOI: https://doi.org/10.1016/S1474-4422(03)00554-4
Martinez-Ramirez D, Walker RH, Rodríguez-Violante M, Gatto EM. Review of hereditary and acquired rare choreas. Tremor and Other Hyperkinetic Movements. 2020; 10(1): 1–24. DOI: https://doi.org/10.5334/tohm.548
Cardoso F. HIV-related movement disorders: Epidemiology, pathogenesis and management. CNS Drugs. 2002; 16(10): 663–8. DOI: https://doi.org/10.2165/00023210-200216100-00002
Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients. Ann Neurol. 1986; 19(3): 224–38. DOI: https://doi.org/10.1002/ana.410190303
Nath A, Jankovic J, Pettigrew LC. Movement disorders and AIDS. Neurology. 1987; 37(January): 37–42. DOI: https://doi.org/10.1212/WNL.37.1.37
Dewey RB, Jankovic J. Hemiballism-hemichorea: clinical and pharmacologic findings in 21 patients. Arch Neurol. 1989; 46(8): 862–7. DOI: https://doi.org/10.1001/archneur.1989.00520440044020
Sanchez-Ramos JR, Factor SA, Weiner WJ, Marquez J. Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis. Mov Disord. 1989; 4(3): 266–73. DOI: https://doi.org/10.1002/mds.870040308
Awada A. Hémiballisme révélateur d’une toxoplasmose cérébrale et d’un syndrome d’immunodéficience acquise [Hemiballismus disclosing cerebral toxoplasmosis and acquired immunodeficiency syndrome]. Rev Neurol (Paris). 1993; 149(6–7): 421–3. French. PMID: 8303164.
Nath A, Hobson DE, Russel A. Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord. 1993; 8(1): 107–12. DOI: https://doi.org/10.1002/mds.870080119
Garretto N, Bueri J, Kremenchutzky M, Consalvo D, Segura M, Genovese O. Hemicorea asociada a toxoplasmosis cerebral y SIDA. Arq Neuropsiquiatr. 1995; 53(1): 118–22. DOI: https://doi.org/10.1590/S0004-282X1995000100018
Manji H, Sweeney B, Connolly S, Hughes A, Miller RF, Harrison MJG. Movement disorders in AIDS: infective, neoplastic and iatrogenic causes. Park Relat Disord. 1995; 1(1): 13–9. DOI: https://doi.org/10.1016/1353-8020(95)00005-Q
Krauss JK, Borremans JJ, Nobbe F, Mundinger F. Ballism not related to vascular disease: a report of 16 patients and review of the literature. Park Relat Disord. 1996; 2(1): 35–45. DOI: https://doi.org/10.1016/1353-8020(95)00018-6
Maggi P, de Mari M, De Blasi R, Armenise S, Romanelli C, Andreula C, et al. Generalized choreoathetosis in an acquired immune deficiency syndrome patient with cerebral toxoplasmosis. Mov Disord. 1996; 11(4): 434–6. DOI: https://doi.org/10.1002/mds.870110414
Piccolo I, Causarano R, Sterzi R, Sberna M, Oreste PL, Moioli C, et al. Chorea in patients with AIDS. Acta Neurol Scand. 1999; 100(5): 332–6. DOI: https://doi.org/10.1111/j.1600-0404.1999.tb00406.x
De Mattos JP, De Rosso ALZ, Corrêa RB, Novis SAP. Movement disorders in 28 HIV-infected patients. Arq Neuropsiquiatr. 2002; 60(3 A): 525–30. DOI: https://doi.org/10.1590/S0004-282X2002000400002
Piccolo I, Defanti CA, Soliveri P, Volontè MA, Cislaghi G, Girotti F. Cause and course in a series of patients with sporadic chorea. J Neurol. 2003; 250(4): 429–35. DOI: https://doi.org/10.1007/s00415-003-1010-7
Rabhi S, Amrani K, Maaroufi M, Khammar Z, Khibri H, Ouazzani M, et al. Hemichorea-hemiballismus as an initial manifestation in a Moroccan patient with acquired immunodeficiency syndrome and toxoplasma infection: a case report and review of the literature. Pan Afr Med J. 2011; 10: 9. DOI: https://doi.org/10.4314/pamj.v10i0.72216
Sta. Maria MAJ, Roxas AA. Hemichorea and myoclonus in Filipino patients with cerebral toxoplasmosis: A report of two cases. Philipp J Neurol. 2012; 16(1): 50. Available at https://www.herdin.ph/index.php?view=research&cid=60423
Moccia M, Picillo M, Carotenuto A, Barbato F, Gentile I, Orefice G. Movement disorders as presenting symptoms of AIDS. Basal Ganglia. 2013; 3(3): 175–8. DOI: https://doi.org/10.1016/j.baga.2013.04.004
Bedwell SF. Some observations on hemiballismus. Neurology. 1960; 10: 619–622. DOI: https://doi.org/10.1212/WNL.10.6.619
Riela A, Roach ES. Choreoathetosis in an infant with tuberculosis meningitis. Arch Neurol. 1982; 39(9): 596. DOI: https://doi.org/10.1001/archneur.1982.00510210066019
Delaporte P, Salama J, Amarenco P. Tuberculome sous-thalamique révélé par un hémiballisme. Efficacité du traitement antituberculeux [Subthalamic tuberculoma disclosed by hemiballism. Efficacy of antituberculous treatment]. Ann Med Interne (Paris). 1983; 134(8): 728–31. French. PMID: 6666911.
Babikian VL, Heydemann PT, Swisher CN. Extrapyramidal movements in a patient with tuberculous meningitis. An early clue to diagnosis. Clin Pediatr (Phila). 1985; 24(2): 113–115. DOI: https://doi.org/10.1177/000992288502400213
Alarcón F, Dueñas G, Cevallos N, Lees AJ. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord. 2000; 15(3): 561–9. DOI: https://doi.org/10.1002/1531-8257(200005)15:3<561::AID-MDS1021>3.0.CO;2-K
Kalita J, Ranjan P, Misra UK, Das BK. Hemichorea: A rare presentation of tuberculoma. J Neurol Sci. 2003; 208(1–2): 109–11. DOI: https://doi.org/10.1016/S0022-510X(02)00417-3
Ozer F, Meral H, Aydemir T, Ozturk O. Hemiballism-hemichorea in presentation of cranial tuberculoma. Mov Disord. 2006; 21(8): 1293–4. DOI: https://doi.org/10.1002/mds.20937
Alarcón F, Maldonado JC, Rivera JW. Movement disorders identified in patients with intracranial tuberculomas. Neurol (English Ed [Internet]). 2011; 26(6): 343–50. DOI: https://doi.org/10.1016/S2173-5808(11)70080-3
Pinto MV, Aguiar T, Nogueira R, Dias AC, Rosso AL. Hemicoreia na meningite tuberculosa. Arq Neuropsiquiatr. 2014; 72(3): 254. DOI: https://doi.org/10.1590/0004-282X20130230
Rubio-Hernandez M, Ortiz-Alvarez A, Tello-Martinez N, Vazquez-Guevara D, Rodriguez-Leyva I. Hemichorea-hemiballism: an uncommon presentation of central nervous system tuberculosis. Mov Disord Clin Pract. 2020; 7(S3): S77–9. DOI: https://doi.org/10.1002/mdc3.13063
Vidal JE. HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease. J Int Assoc Provid AIDS Care. 2019; 18: 1–20. DOI: https://doi.org/10.1177/2325958219867315
Shih RY, Koeller KK. Bacterial, fungal, and parasitic infections of the central nervous system: radiologic-pathologic correlation and historical perspectives. Radiographics. 2015; 35(4): 1141–1169. DOI: https://doi.org/10.1148/rg.2015140317
Rath TJ, Hughes M, Arabi M, Shah GV. Imaging of cerebritis, encephalitis, and brain abscess. Neuroimaging Clin N Am. 2012; 22(4): 585–607. DOI: https://doi.org/10.1016/j.nic.2012.04.002
Tuazon CU. Toxoplasmosis in AIDS patients. J Antimicrob Chemother. 1989; 23(Suppl A): 77–82. DOI: https://doi.org/10.1093/jac/23.suppl_A.77
Nelson CA, Zunt JR. Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clinical Infectious Diseases. 2011; 53(9): 915–26. DOI: https://doi.org/10.1093/cid/cir508
Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol. 2006; 61(5): 393–401. DOI: https://doi.org/10.1016/j.crad.2006.01.008
Carroll E, Sanchez-Ramos J. Hyperkinetic movement disorders associated with HIV and other viral infections. In: Weiner WJ, Tolosa E, editors. Handbook of Clinical Neurology, 1st ed. Vol. 100. Elsevier B.V.; 2011; 323–334. DOI: https://doi.org/10.1016/B978-0-444-52014-2.00025-2
Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW. From the archives of the AFIP: patterns of contrast enhancement in the brain and meninges. Radiographics. 2007; 27(2): 525–51. DOI: https://doi.org/10.1148/rg.272065155
Taheri MS, Karimi MA, Haghighatkhah H, Pourghorban R, Samadian M, Kasmaei HD. Central nervous system tuberculosis: an imaging-focused review of a reemerging disease. Radiol Res Pract. 2015; 2015: 1–8. DOI: https://doi.org/10.1155/2015/202806
Singh KK, Nair MD, Radhakrishnan K, Tyagi JS. Utility of PCR assay in diagnosis of en-plaque tuberculoma of the brain. J Clin Microbiol. 1999; 37(2): 467–70. DOI: https://doi.org/10.1128/JCM.37.2.467-470.1999
Monno L, Angarano G, Romanelli C, Giannelli A, Appice A, Carbonara S, et al. Polymerase chain reaction for non-invasive diagnosis of brain mass lesions caused by mycobacterium tuberculosis: report of five cases in human immunodeficiency virus-positive subjects. Tuber Lung Dis. 1996; 77(3): 280–4. DOI: https://doi.org/10.1016/S0962-8479(96)90014-3
Delance AR, Safaee M, Oh MC, Clark AJ, Kaur G, Sun MZ, et al. Tuberculoma of the central nervous system. J Clin Neurosci [Internet]. 2013; 20(10): 1333–41. DOI: https://doi.org/10.1016/j.jocn.2013.01.008
Martino D, Espay AJ, Fasano A, Morgante F. (eds.). Disorders of movement: a guide to diagnosis and treatment. 2016; 322–350. Berlin Heidelberg: Springer-Verlag. DOI: https://doi.org/10.1007/978-3-662-48468-5
Philippine Society for Microbiology and Infectious Diseases. Task force: Philippine clinical practice guidelines for the prevention, diagnosis, and treatment of opportunistic infections in human immunodeficiency virus-infected adults and adolescents in the Philippines. Quezon City: Published by the Philippine Society for Microbiology and Infectious Diseases (PSMID), Inc.; 2016; 89–100, 153–160.